Back to Search
Start Over
Approach to Fingolimod-Induced Lymphopenia in Multiple Sclerosis Patients: Do We Have a Roadmap?
- Source :
-
Journal of Clinical Pharmacology . Nov2017, Vol. 57 Issue 11, p1415-1418. 4p. - Publication Year :
- 2017
-
Abstract
- The article discusses the role of fingolimod (FTY) in inducing lymphopenia in multiple sclerosis(MS) patients and implications post withdrawal of FTY. It refers to a study in which a patient developed a rebound syndrome within four weeks post cessation of the drug, characterized by hemiparesis and imbalance of gait. It suggests clinicians should systematically collect and examine laboratory and imaging data to understand the risks of prolonged lymphopenia during FTY use in MS.
Details
- Language :
- English
- ISSN :
- 00912700
- Volume :
- 57
- Issue :
- 11
- Database :
- Academic Search Index
- Journal :
- Journal of Clinical Pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 125581898
- Full Text :
- https://doi.org/10.1002/jcph.945